ADHD Home > Metadate ER Uses
Metadate ER uses include the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. The medication can be used in children ages six and older, but is not approved for treating ADHD in adults. On occasion, healthcare providers may recommend off-label Metadate ER uses, such as the treatment of depression, weight loss, and the treatment of adult ADHD.
Metadate ER® (methylphenidate extended-release) is a prescription medicine commonly used for the treatment of:
ADHD is a condition involving difficulty paying attention, sitting still, and controlling behavior. In ADHD, these problems are worse than expected for a typical child of the same age. Usually, the symptoms must be present before the age of seven to qualify as ADHD. The symptoms must also affect school, work, or social life in a negative way (see ADHD and School and Relationships and ADHD for more information).
Although ADHD is generally thought of as a problem in children, teenagers and adults can also have it. The process used to diagnose the condition in adults is different from that used to diagnose it in children, and Metadate ER is not approved for adult ADHD (see Metadate and Adults).
Any behavioral change involves a well-balanced ADHD treatment plan, including social, educational, and mental therapy (see Behavior Therapy for ADHD). If lifestyle changes alone are not effective in changing behavior, ADHD medications (such as Metadate ER) may be necessary.
Metadate ER is a stimulant, but it can have effects that are opposite from what would be expected of a stimulant. While stimulants (like caffeine) can cause hyperactivity, when used at doses to treat ADHD, Metadate ER usually has a calming effect. Although it is not known exactly how the drug achieves this, it is known that it affects certain chemicals in the brain (see Methylphenidate and D2 Receptors for more information).